FERRING PHARMACEUTICALS A/S: Financial statements 2022
CVR: 16313440
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
FERRING PHARMACEUTICALS A/S (CVR 16313440) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,261,432,000 and a net result of DKK 52,377,000 compared with DKK 40,174,000 the year before. That is an increase of 25.5% compared with the year before. The profit margin was 4.2%. Equity in the 2022 report amounted to DKK 121,995,000. The solvency ratio was 25.1%. The company had 559 employees in the financial year.
- Revenue
- DKK 1,261,432,000
- Gross Profit
- DKK 645,934,000
- Profit/Loss
- DKK 52,377,000
- Equity
- DKK 121,995,000
- Total Assets
- DKK 485,671,000
- Employees
- 559
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 1.3B | 645.9M | 52.4M | 122M | 559 |
| 2021 | 1B | 1B | 40.2M | 69.6M | 487 |
| 2020 | 1.1B | 1.1B | 40.9M | 79.4M | 497 |
| 2019 | 1.4B | 1.4B | 38.3M | 106.5M | 533 |
| 2018 | 1.4B | 1.4B | 56.1M | 118.2M | 525 |
Official annual report
Keep an eye on FERRING PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
FERRING PHARMACEUTICALS A/S has published its annual report for 2021. Revenue came to DKK 1,005,468,000, and the net result was DKK 40,174,000.
About FERRING PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Ingbritt Tolstrup Birk and Jesper Thomsen. The board consists of Marianne Kock (chair), Dag Frederik Arfst Paulsen and Jean-Frederic Paulsen. The company is owned by Ferring B.V.. The company has 522 employees (2026). In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity in the 2025 report amounted to DKK 315,220,000.